Announcements Trials
Browse Landscape

Phase

Phase 2 37Phase 1/2 18Phase 1 7Phase 3 5Phase NA 3Phase EARLY_PHASE1 3Phase 4 2Phase 2/3 1

Status

Completed 21Recruiting 9Unknown 7Terminated 5Active not recruiting 4Withdrawn 3Not yet recruiting 3Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1CNS 1Breast 1

Conditions

Pancreatic Neoplasms 1Glioblastoma 1Breast Neoplasms 1

Interventions

Radiosurgery 20Magnetic Resonance Spectroscopy 20Exercise 15Biopsy 11Surveys and Questionnaires 9Standard of Care 9Cyclophosphamide 9Educational Status 8Practice Guidelines as Topic 7Doxorubicin 7Cisplatin 7Therapeutics 6Radiotherapy 6Methods 6Fluorodeoxyglucose F18 6Early Intervention, Educational 6Blood Specimen Collection 6Radiotherapy, Intensity-Modulated 5Electroporation 5Cryosurgery 5Colonoscopy 5X-Rays 4Water 4Vincristine 4Polymerase Chain Reaction 4Palliative Care 4Irinotecan 4Drug Therapy 4Diet Therapy 4Cryotherapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Withdrawn × Bevacizumab × Clear all
NCT05410301 2023-04-21

Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma

University of Iowa

Phase NA Withdrawn
CNS

Glioblastoma

NCT00524069 2013-02-01

Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

Roswell Park Cancer Institute

Phase NA Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT01159236 2012-07-31

Molecular Triaging of Newly Diagnosed Breast Cancer

M.D. Anderson Cancer Center

Phase NA Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡